Improving Myeloma Outcomes

Ajai Chari, MD

Video Categories: Hematological Malignancies

Dr. Ajai Chari discusses the ultimate goal of improving therapy for myeloma patients. He mentions the COMPASS study, which is working to collect a database of clinical and scientific information on 1000 patients. In the interim, there are some clues, such as an understanding of certain high-molecular-risk patients and some evidence of certain subgroups that have increased response to some new drugs. This allows physicians to be more selective for those who are most likely to benefit from certain therapies.
September 20, 2013

The Value of Personalized Medicine

John Hennessy provides a few benefits of personalized medicine as it effects the ability to make better treatment choices earlier rather than later

January 10, 2019

Immunotherapy vs Targeted Therapy

Dr Morganna Freeman explains the difference between immunotherapies and targeted therapies in plain language for patients to easily understand.